Related Experiment Video
Updated: Jun 5, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.7K
Systematic Automated Population-Based Surveillance to Improve Outcomes in Primary Cutaneous Melanoma
Allison Ching1, Kathryn Pedula2, Theresa Devere2
1Kaiser Permanente Hawaii, Honolulu, HI, USA.
Journal of Primary Care & Community Health
|December 16, 2024
Summary
A systematic automated program for melanoma patients significantly improved follow-up compliance and early detection of second primary melanomas (SPMs). This led to reduced mortality, enhancing patient safety and care efficiency.
Area of Science:
- Dermatology
- Oncology
- Public Health Surveillance
Background:
- Patients with primary cutaneous melanoma (PCM) face an elevated risk of developing a second primary melanoma (SPM).
- Low compliance with recommended follow-up care and high patient dropout rates hinder effective surveillance for SPMs.
- Existing strategies for population-based SPM surveillance lack comprehensive description.
Purpose of the Study:
- To evaluate if a systematic automated population-based program (SAPP) for total body skin exams (TBSEs) in PCM patients improves follow-up compliance.
- To determine if the SAPP enhances the detection of SPMs and impacts mortality rates compared to pre-automated and pre-database periods.
Main Methods:
- A quality improvement study was conducted within a large integrated healthcare system.
- Included 6317 patients with PCM across three periods: pre-Database (2005-2009), pre-Automation (2009-2015), and post-Automation (2015-2021).
- Interventions involved a manual registry (pre-Automation) and a systematic automated program (post-Automation) for ensuring dermatologist TBSEs.
Main Results:
- The SAPP significantly reduced the median time between TBSEs for both early and advanced stage PCM patients (P < .0001).
- The number of TBSEs per person-year increased across study periods, with a notable rise in the post-automation phase (P < .0001).
- SPM detection rates improved, with SPMs diagnosed at earlier stages (P < .0001 for trend), alongside significant reductions in all-cause and melanoma-specific mortality.
Conclusions:
- Implementation of a systematic, automated population-based program for dermatologist TBSEs enhances follow-up compliance in PCM patients.
- The program led to increased annual TBSEs, earlier SPM detection, and sustained improvements, including significantly lower mortality rates.
- This automated system offers a strategy for prioritizing high-risk patients, improving patient safety, care efficiency, and timeliness.
Related Concept Videos
Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
Kaplan-Meier Approach
94
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
94

